Willie Deese - Dentsply Sirona Independent Director
| XRAY Stock | USD 30.44 0.08 0.26% |
Director
Mr. Willie A. Deese is an Independent Director of the Company. Mr. Deese retired from Merck Co., Inc., a global pharmaceutical company, on June 1, 2016 after serving as Executive Vice President since 2008 and President of the Merck Manufacturing Division since 2005. He was also a member of Mercks Executive Committee since 2011.
| Age | 62 |
| Tenure | 13 years |
| Address | 13320-B Ballantyne Corporate Place, Charlotte, NC, United States, 28277-3607 |
| Phone | 844 848 0137 |
| Web | https://www.dentsplysirona.com |
Dentsply Sirona Management Efficiency
The company has return on total asset (ROA) of 0.0241 % which means that it generated a profit of $0.0241 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0372) %, meaning that it created substantial loss on money invested by shareholders. Dentsply Sirona's management efficiency ratios could be used to measure how well Dentsply Sirona manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.04 in 2024. Return On Capital Employed is likely to drop to 0.05 in 2024. At this time, Dentsply Sirona's Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to rise to about 271.9 M in 2024, whereas Total Assets are likely to drop slightly above 3.7 B in 2024.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| William Parrett | Thermo Fisher Scientific | 71 | |
| Dipchand Nishar | Guardant Health | N/A | |
| Richard Francis | Mettler Toledo International | 52 | |
| Martin Harris | Thermo Fisher Scientific | 61 | |
| Connie Harvey | Mettler Toledo International | 52 | |
| Sue Rataj | Agilent Technologies | 63 | |
| Ian Clark | Guardant Health | 57 | |
| Virginia Wilson | Charles River Laboratories | 66 | |
| Martin Mackay | Charles River Laboratories | 65 | |
| Samir Kaul | Guardant Health | 44 | |
| Christopher Kuebler | Waters | 66 | |
| Gary Guthart | Illumina | 52 | |
| Joshua Bekenstein | Waters | 56 | |
| James Mullen | Thermo Fisher Scientific | 62 | |
| Arthur Bowman | Illumina | 69 | |
| Michael Berendt | Waters | 71 | |
| Frances Arnold | Illumina | 61 | |
| Wah Chu | Mettler Toledo International | 62 | |
| Elisha Finney | Mettler Toledo International | 59 | |
| Constance Harvey | Mettler Toledo International | 56 | |
| Nancy Andrews | Charles River Laboratories | 63 | |
Management Performance
| Return On Equity | -0.0372 | ||||
| Return On Asset | 0.0241 |
Dentsply Sirona Leadership Team
Elected by the shareholders, the Dentsply Sirona's board of directors comprises two types of representatives: Dentsply Sirona inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dentsply. The board's role is to monitor Dentsply Sirona's management team and ensure that shareholders' interests are well served. Dentsply Sirona's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dentsply Sirona's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Maureen MacInnis, Chief Human Resource Officer, Senior Vice President | ||
| Dan Workinger, Treasurer | ||
| Thomas Jetter, Lead Director, Independent Director | ||
| Paula Cholmondeley, Independent Director | ||
| Lisa Yankie, VP Officer | ||
| Francis Lunger, Independent Director | ||
| Andrew Robinson, VP Officer | ||
| Kevin Boyle, Senior Officer | ||
| Christopher Clark, Pres and CFO | ||
| Deborah Rasin, Vice President General Counsel, Secretary | ||
| Betsy Holden, Director | ||
| Donald Casey, CEO, Director | ||
| Derek Leckow, VP, Investor Relations | ||
| Andreas Frank, Executive Officer | ||
| Nicholas Alexos, Executive Vice President Chief Administrative Officer | ||
| Daniel Key, Senior Vice President Chief Supply Chain Officer | ||
| Justin McCarthy, General Counsel, Secretary | ||
| Albert Sterkenburg, Senior Vice President | ||
| Markus Boehringer, Senior Vice President - EMEA RCO | ||
| Erania Brackett, SVP Sustainability | ||
| Walter Petersohn, Senior Vice President Chief Commercial Officer | ||
| William Hecht, Lead Independent Director | ||
| Jonathan Friedman, Senior Vice President General Counsel, Secretary | ||
| Mark Thierer, Interim CEO | ||
| Cord Staehler, VP CTO | ||
| Bret Wise, Chairman, CEO and Chairman of Executive Committee | ||
| Glenn Coleman, Executive CFO | ||
| Henning Mueller, Group Vice President - Asia Pacific RCO | ||
| Ulrich Michel, CFO, Executive Vice President | ||
| Rainer Berthan, Executive Vice President Manufacturing and Supply Chain | ||
| Richard Wagner, Chief Officer | ||
| Cheree Johnson, Chief VP | ||
| Dane Baumgardner, AttorneyInFact | ||
| John Sweeney, vice president IR Contact Officer | ||
| Eric Bruno, Senior Vice President - North America Regional Commercial Organization | ||
| Jorge Gomez, CFO, Executive Vice President | ||
| Andrea Daley, Vice Relations | ||
| Robert Size, Sr. VP | ||
| Harry Kraemer, Director | ||
| Andrea Frohning, Senior Officer | ||
| Michael Coleman, Independent Director | ||
| David Beecken, Director | ||
| Leslie Varon, Director | ||
| Eric Brandt, Independent Director | ||
| Robert Johnson, Senior Officer | ||
| William Newell, Senior Vice President Chief Segment Officer | ||
| Willie Deese, Independent Director | ||
| Simon Campion, President CEO | ||
| Keith Ebling, Executive Vice President General Counsel, Secretary | ||
| John Miles, Independent Director | ||
| Richard Rosenzweig, General Development | ||
| Michael Alfano, Independent Director | ||
| James Mosch, COO and Executive VP | ||
| Emily Miner, Senior Officer | ||
| John Miclot, Independent Director | ||
| Arthur Kowaloff, Director | ||
| Jeffrey Slovin, CEO, Director |
Dentsply Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dentsply Sirona a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0372 | ||||
| Return On Asset | 0.0241 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 8.34 B | ||||
| Shares Outstanding | 207.63 M | ||||
| Shares Owned By Insiders | 0.36 % | ||||
| Shares Owned By Institutions | 99.64 % | ||||
| Number Of Shares Shorted | 10.46 M | ||||
| Price To Earning | 19.16 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Dentsply Sirona offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dentsply Sirona's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dentsply Sirona Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dentsply Sirona Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Dentsply Sirona. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Dentsply Stock please use our How to Invest in Dentsply Sirona guide.Note that the Dentsply Sirona information on this page should be used as a complementary analysis to other Dentsply Sirona's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Dentsply Stock analysis
When running Dentsply Sirona's price analysis, check to measure Dentsply Sirona's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dentsply Sirona is operating at the current time. Most of Dentsply Sirona's value examination focuses on studying past and present price action to predict the probability of Dentsply Sirona's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dentsply Sirona's price. Additionally, you may evaluate how the addition of Dentsply Sirona to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Dentsply Sirona's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dentsply Sirona. If investors know Dentsply will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dentsply Sirona listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.178 | Dividend Share 0.56 | Earnings Share (0.62) | Revenue Per Share 18.703 | Quarterly Revenue Growth 0.03 |
The market value of Dentsply Sirona is measured differently than its book value, which is the value of Dentsply that is recorded on the company's balance sheet. Investors also form their own opinion of Dentsply Sirona's value that differs from its market value or its book value, called intrinsic value, which is Dentsply Sirona's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dentsply Sirona's market value can be influenced by many factors that don't directly affect Dentsply Sirona's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dentsply Sirona's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dentsply Sirona is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dentsply Sirona's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.